Document is current

Article History

Accepted: 31 May 2022

First Online: 1 July 2022

Declarations

:

: Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002.

: Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002. Dorra Bouazzi declares that she has no conflict of interest. Gregor B.E. Jemec reports grants and personal fees from AbbVie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work.

: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

: Ethics approval is not required as this is a literature review.

: Informed consent was not obtained as this is a literature review of already published studies.

: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Mattias A.S. Henning, Dorra Bouazzi and Gregor B.E. Jemec. The first draft of the manuscript was written by Mattias A.S. Henning and all authors commented on previous versions of the manuscript. All authors read and approved the final article.

: Not applicable.